These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25113878)

  • 21. A convergent synthesis of alkyne-azide cycloaddition derivatives of 4-α,β-2-propyne podophyllotoxin depicting potent cytotoxic activity.
    Zilla MK; Nayak D; Vishwakarma RA; Sharma PR; Goswami A; Ali A
    Eur J Med Chem; 2014 Apr; 77():47-55. PubMed ID: 24607588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents.
    Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C
    Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual inhibition of topoisomerase II and microtubule of podophyllotoxin derivative 5p overcomes cancer multidrug resistance.
    Lv X; Cheng WH; Li XX; Shang H; Zhang JY; Hong HY; Zheng YJ; Dong YQ; Gong JH; Zheng YB; Zou ZM
    Eur J Pharmacol; 2024 Nov; 983():176968. PubMed ID: 39233039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
    Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ
    Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of 4α/4β-imidazolyl podophyllotoxin analogues as antitumor agents.
    Shang H; Chen H; Zhao D; Tang X; Liu Y; Pan L; Cheng M
    Arch Pharm (Weinheim); 2012 Jan; 345(1):43-8. PubMed ID: 21956645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and cytotoxicity evaluation of novel podophyllotoxin derivatives.
    Chengniu W; Zhonghua W; Yu Z; Chunyan N; Xiaodong Z; Li Z
    Arch Pharm (Weinheim); 2011 Nov; 344(11):735-40. PubMed ID: 21887802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and evaluation of the multidrug resistance-reversing activity of pyridine acid esters of podophyllotoxin in human leukemia cells.
    Zhang L; Chen F; Zhang Z; Chen Y; Lin Y; Wang J
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4466-4471. PubMed ID: 27503681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Synthesis and antitumor activity of novel indole podophyllotoxin derivatives].
    Tian DL; Liang CP; Liang J; Chen H
    Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2532-2537. PubMed ID: 31359720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of novel conjugates of podophyllotoxin and 5-FU as antineoplastic agents.
    Chen SW; Xiang R; Liu J; Tian X
    Bioorg Med Chem; 2009 Apr; 17(8):3111-7. PubMed ID: 19324555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
    Rothenborg-Jensen L; Hansen HF; Wessel I; Nitiss JL; Schmidt G; Jensen PB; Sehested M; Jensen LH
    Anticancer Drug Des; 2001 Dec; 16(6):305-15. PubMed ID: 12375883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins.
    Hu Y; Cheng X; Li S; Zhou Y; Wang J; Cheng T; Yang M; Xiong D
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):789-98. PubMed ID: 24013575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of new 4β-anilino-4'-O-demethyl-4-desoxypodophyllotoxin derivatives as potential antitumor agents.
    Wang L; Yang F; Yang X; Guan X; Hu C; Liu T; He Q; Yang B; Hu Y
    Eur J Med Chem; 2011 Jan; 46(1):285-96. PubMed ID: 21145139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-pot synthesis and biological evaluation of N-(aminosulfonyl)-4-podophyllotoxin carbamates as potential anticancer agents.
    Xu XH; Guan XW; Feng SL; Ma YZ; Chen SW; Hui L
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2890-2894. PubMed ID: 28512026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of podophyllotoxin derivatives as selective antitumor agents.
    Wu GR; Xu B; Yang YQ; Zhang XY; Fang K; Ma T; Wang H; Xue NN; Chen M; Guo WB; Jia XH; Wang PL; Lei HM
    Eur J Med Chem; 2018 Jul; 155():183-196. PubMed ID: 29886322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of mdr1-mediated multidrug resistance in human leukemia cells by a new spin-labeled derivative of podophyllotoxin.
    Qi SN; Song LJ; Chen Y; Jing YX
    Pharmazie; 2010 Feb; 65(2):117-21. PubMed ID: 20225656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Semi-synthesis and biological evaluation of 1,2,3-triazole-based podophyllotoxin congeners as potent antitumor agents inducing apoptosis in HepG2 cells.
    Chen J; Ma L; Zhang R; Tang J; Lai H; Wang J; Wang G; Xu Q; Chen T; Peng F; Qiu J; Liang X; Cao D; Ran Y; Peng A; Wei Y; Chen L
    Arch Pharm (Weinheim); 2012 Dec; 345(12):945-56. PubMed ID: 22949330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of derivatives of 4-deoxypodophyllotoxin as antitumor agents.
    Jin Y; Liu J; Huang WT; Chen SW; Hui L
    Eur J Med Chem; 2011 Sep; 46(9):4056-61. PubMed ID: 21733601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
    J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and multidrug resistance reversal activity of dihydroptychantol A and its novel derivatives.
    Sun B; Yuan HQ; Xi GM; Ma YD; Lou HX
    Bioorg Med Chem; 2009 Jul; 17(14):4981-9. PubMed ID: 19540127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.